GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Putative phospholipase B-like 2 (EC 3.1.1.-) (76 kDa protein) (p76) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2) [Cleaved into: Putative phospholipase B-like 2 32 kDa form; Putative phospholipase B-like 2 45 kDa form]

 PLBL2_HUMAN             Reviewed;         589 AA.
Q8NHP8; F5H5E2;
01-MAY-2007, integrated into UniProtKB/Swiss-Prot.
03-MAR-2009, sequence version 2.
16-JAN-2019, entry version 111.
RecName: Full=Putative phospholipase B-like 2;
EC=3.1.1.-;
AltName: Full=76 kDa protein;
Short=p76;
AltName: Full=LAMA-like protein 2;
AltName: Full=Lamina ancestor homolog 2;
AltName: Full=Phospholipase B domain-containing protein 2;
Contains:
RecName: Full=Putative phospholipase B-like 2 32 kDa form;
Contains:
RecName: Full=Putative phospholipase B-like 2 45 kDa form;
Flags: Precursor;
Name=PLBD2;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=16541075; DOI=10.1038/nature04569;
Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
Kucherlapati R., Weinstock G., Gibbs R.A.;
"The finished DNA sequence of human chromosome 12.";
Nature 440:346-351(2006).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
TISSUE=Testis;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[3]
PROTEIN SEQUENCE OF 42-49 AND 244-250, GLYCOSYLATION AT ASN-88;
ASN-110; ASN-231; ASN-436; ASN-465 AND ASN-515, INTERACTION WITH
IGF2R, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND IDENTIFICATION BY
MASS SPECTROMETRY.
PubMed=17105447; DOI=10.1042/BJ20061205;
Jensen A.G., Chemali M., Chapel A., Kieffer-Jaquinod S., Jadot M.,
Garin J., Journet A.;
"Biochemical characterization and lysosomal localization of the
mannose-6-phosphate protein p76 (hypothetical protein LOC196463).";
Biochem. J. 402:449-458(2007).
[4]
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-465.
TISSUE=Liver;
PubMed=19159218; DOI=10.1021/pr8008012;
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
"Glycoproteomics analysis of human liver tissue by combination of
multiple enzyme digestion and hydrazide chemistry.";
J. Proteome Res. 8:651-661(2009).
[5]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=21269460; DOI=10.1186/1752-0509-5-17;
Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
"Initial characterization of the human central proteome.";
BMC Syst. Biol. 5:17-17(2011).
[6]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=25944712; DOI=10.1002/pmic.201400617;
Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
"N-terminome analysis of the human mitochondrial proteome.";
Proteomics 15:2519-2524(2015).
-!- FUNCTION: Putative phospholipase. {ECO:0000250}.
-!- SUBUNIT: Interacts with IGF2R. {ECO:0000269|PubMed:17105447}.
-!- SUBCELLULAR LOCATION: Lysosome lumen
{ECO:0000269|PubMed:17105447}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=1;
IsoId=Q8NHP8-1; Sequence=Displayed;
Name=2;
IsoId=Q8NHP8-2; Sequence=VSP_055623;
Note=No experimental confirmation available.;
-!- TISSUE SPECIFICITY: Ubiquitously expressed, with highest levels in
heart, brain and liver. {ECO:0000269|PubMed:17105447}.
-!- PTM: The p76 protein is synthesized as a 80 kDa precursor which is
then processed into a N-terminal 32 kDa form and a C-terminal 45
kDa form.
-!- PTM: Glycosylated; contains mannose 6-phosphate sugars.
{ECO:0000269|PubMed:17105447, ECO:0000269|PubMed:19159218}.
-!- SIMILARITY: Belongs to the phospholipase B-like family.
{ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AC010178; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC030618; AAH30618.1; -; mRNA.
EMBL; BC071832; -; NOT_ANNOTATED_CDS; mRNA.
CCDS; CCDS53834.1; -. [Q8NHP8-2]
CCDS; CCDS9168.1; -. [Q8NHP8-1]
RefSeq; NP_001153199.1; NM_001159727.1. [Q8NHP8-2]
RefSeq; NP_775813.2; NM_173542.3. [Q8NHP8-1]
UniGene; Hs.115896; -.
ProteinModelPortal; Q8NHP8; -.
SMR; Q8NHP8; -.
BioGrid; 128208; 16.
IntAct; Q8NHP8; 10.
STRING; 9606.ENSP00000280800; -.
MEROPS; C95.001; -.
GlyConnect; 1700; -.
iPTMnet; Q8NHP8; -.
PhosphoSitePlus; Q8NHP8; -.
BioMuta; PLBD2; -.
DMDM; 224471847; -.
EPD; Q8NHP8; -.
jPOST; Q8NHP8; -.
MaxQB; Q8NHP8; -.
PaxDb; Q8NHP8; -.
PeptideAtlas; Q8NHP8; -.
PRIDE; Q8NHP8; -.
ProteomicsDB; 73733; -.
Ensembl; ENST00000280800; ENSP00000280800; ENSG00000151176. [Q8NHP8-1]
Ensembl; ENST00000545182; ENSP00000443463; ENSG00000151176. [Q8NHP8-2]
GeneID; 196463; -.
KEGG; hsa:196463; -.
UCSC; uc001tve.3; human. [Q8NHP8-1]
CTD; 196463; -.
EuPathDB; HostDB:ENSG00000151176.7; -.
GeneCards; PLBD2; -.
HGNC; HGNC:27283; PLBD2.
HPA; HPA017163; -.
neXtProt; NX_Q8NHP8; -.
OpenTargets; ENSG00000151176; -.
PharmGKB; PA164724624; -.
eggNOG; KOG3774; Eukaryota.
eggNOG; ENOG410XQRV; LUCA.
GeneTree; ENSGT00530000063509; -.
HOGENOM; HOG000006903; -.
HOVERGEN; HBG096591; -.
InParanoid; Q8NHP8; -.
OMA; ETTIGNR; -.
OrthoDB; 724258at2759; -.
PhylomeDB; Q8NHP8; -.
TreeFam; TF315042; -.
ChiTaRS; PLBD2; human.
GenomeRNAi; 196463; -.
PRO; PR:Q8NHP8; -.
Proteomes; UP000005640; Chromosome 12.
Bgee; ENSG00000151176; Expressed in 201 organ(s), highest expression level in left adrenal gland.
ExpressionAtlas; Q8NHP8; baseline and differential.
Genevisible; Q8NHP8; HS.
GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
GO; GO:0043202; C:lysosomal lumen; IEA:UniProtKB-SubCell.
GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
InterPro; IPR007000; PLipase_B-like.
PANTHER; PTHR12370; PTHR12370; 1.
Pfam; PF04916; Phospholip_B; 1.
1: Evidence at protein level;
Alternative splicing; Complete proteome; Direct protein sequencing;
Disulfide bond; Glycoprotein; Hydrolase; Lipid degradation;
Lipid metabolism; Lysosome; Polymorphism; Reference proteome; Signal.
SIGNAL 1 41 {ECO:0000269|PubMed:17105447}.
CHAIN 42 589 Putative phospholipase B-like 2.
/FTId=PRO_0000286110.
CHAIN 42 243 Putative phospholipase B-like 2 32 kDa
form.
/FTId=PRO_0000314074.
CHAIN 244 589 Putative phospholipase B-like 2 45 kDa
form.
/FTId=PRO_0000314075.
CARBOHYD 88 88 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:17105447}.
CARBOHYD 110 110 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:17105447}.
CARBOHYD 231 231 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:17105447}.
CARBOHYD 436 436 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:17105447}.
CARBOHYD 465 465 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:17105447,
ECO:0000269|PubMed:19159218}.
CARBOHYD 515 515 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:17105447}.
DISULFID 142 152 {ECO:0000250}.
DISULFID 492 495 {ECO:0000250}.
VAR_SEQ 374 405 Missing (in isoform 2).
{ECO:0000303|PubMed:15489334}.
/FTId=VSP_055623.
VARIANT 54 54 Q -> P (in dbSNP:rs7965471).
/FTId=VAR_062187.
VARIANT 524 524 R -> C (in dbSNP:rs12425042).
/FTId=VAR_032075.
CONFLICT 521 521 Q -> K (in Ref. 2; AAH30618).
{ECO:0000305}.
SEQUENCE 589 AA; 65472 MW; D0D1BACCFBF756BB CRC64;
MVGQMYCYPG SHLARALTRA LALALVLALL VGPFLSGLAG AIPAPGGRWA RDGQVPPASR
SRSVLLDVSA GQLLMVDGRH PDAVAWANLT NAIRETGWAF LELGTSGQYN DSLQAYAAGV
VEAAVSEELI YMHWMNTVVN YCGPFEYEVG YCERLKSFLE ANLEWMQEEM ESNPDSPYWH
QVRLTLLQLK GLEDSYEGRV SFPAGKFTIK PLGFLLLQLS GDLEDLELAL NKTKIKPSLG
SGSCSALIKL LPGQSDLLVA HNTWNNYQHM LRVIKKYWLQ FREGPWGDYP LVPGNKLVFS
SYPGTIFSCD DFYILGSGLV TLETTIGNKN PALWKYVRPR GCVLEWVRNI VANRLASDGA
TWADIFKRFN SGTYNNQWMI VDYKAFIPGG PSPGSRVLTI LEQIPGMVVV ADKTSELYQK
TYWASYNIPS FETVFNASGL QALVAQYGDW FSYDGSPRAQ IFRRNQSLVQ DMDSMVRLMR
YNDFLHDPLS LCKACNPQPN GENAISARSD LNPANGSYPF QALRQRSHGG IDVKVTSMSL
ARILSLLAAS GPTWDQVPPF QWSTSPFSGL LHMGQPDLWK FAPVKVSWD


Related products :

Catalog number Product name Quantity
EIAAB31414 Bos taurus,Bovine,LAMA-like protein 2,Lamina ancestor homolog 2,Phospholipase B domain-containing protein 2,PLBD2,Putative phospholipase B-like 2
EIAAB31413 LAMA-like protein 2,Lamina ancestor homolog 2,Phospholipase B domain-containing protein 2,Plbd2,Putative phospholipase B-like 2,Rat,Rattus norvegicus,RDCR-0918-3
EIAAB31412 76 kDa protein,Homo sapiens,Human,LAMA-like protein 2,Lamina ancestor homolog 2,p76,Phospholipase B domain-containing protein 2,PLBD2,Putative phospholipase B-like 2
EIAAB31415 66.3 kDa protein,76 kDa protein,LAMA-like protein 2,Lamina ancestor homolog 2,Mouse,Mus musculus,p76,Phospholipase B domain-containing protein 2,Plbd2,Putative phospholipase B-like 2
EIAAB31409 Bos taurus,Bovine,LAMA-like protein 1,Lamina ancestor homolog 1,Phospholipase B domain-containing protein 1,Phospholipase B-like 1,PLBD1
EIAAB31410 LAMA-like protein 1,Lamina ancestor homolog 1,Mouse,Mus musculus,Phospholipase B domain-containing protein 1,Phospholipase B-like 1,Plbd1
EIAAB31411 LAMA-like protein 1,Lamina ancestor homolog 1,Phospholipase B domain-containing protein 1,Phospholipase B-like 1,Plbd1,Rat,Rattus norvegicus
EIAAB31408 Homo sapiens,Human,LAMA-like protein 1,Lamina ancestor homolog 1,Phospholipase B domain-containing protein 1,Phospholipase B-like 1,PLBD1
EIAAB31460 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase eta-1,Kiaa1069,Mouse,Mus musculus,Phosphoinositide phospholipase C-eta-1,Phospholipase C-eta-1,Phospholipase C-like protein 3,PLC-eta-1,Plch1,
EIAAB31459 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase eta-1,Homo sapiens,Human,KIAA1069,Phosphoinositide phospholipase C-eta-1,Phospholipase C-eta-1,Phospholipase C-like protein 3,PLC-eta-1,PLCH1,
EIAAB31407 Oryctolagus cuniculus,Phospholipase AdRab-B,Phospholipase B,Phospholipase B_lipase,Phospholipase B1, membrane-associated,PLB_LIP,PLB1,Rabbit
EIAAB31464 Homo sapiens,Human,Inactive phospholipase C-like protein 1,Phospholipase C-deleted in lung carcinoma,Phospholipase C-related but catalytically inactive protein,PLCL1,PLC-L1,PRIP
EIAAB10717 DDHD domain-containing protein 1,Ddhd1,Mouse,Mus musculus,PA-PLA1,Phosphatidic acid-preferring phospholipase A1 homolog,Phospholipase DDHD1
EIAAB31466 Homo sapiens,Human,Inactive phospholipase C-like protein 2,KIAA1092,Phospholipase C-epsilon-2,Phospholipase C-L2,PLCE2,PLC-epsilon-2,PLC-L(2),PLCL2,PLC-L2
EIAAB31495 Choline phosphatase 6,Homo sapiens,Human,Mitochondrial cardiolipin hydrolase,Mitochondrial phospholipase,MitoPLD,Phosphatidylcholine-hydrolyzing phospholipase D6,Phospholipase D6,PLD 6,PLD6,Protein zu
EIAAB10716 DDHD domain-containing protein 1,DDHD1,Homo sapiens,Human,KIAA1705,PA-PLA1,Phosphatidic acid-preferring phospholipase A1 homolog,Phospholipase DDHD1
EIAAB31467 Inactive phospholipase C-like protein 2,Kiaa1092,Mouse,Mus musculus,Phospholipase C-epsilon-2,Phospholipase C-L2,Plce2,PLC-epsilon-2,PLC-L(2),Plcl2,PLC-L2
EIAAB31461 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase eta-2,Mouse,Mus musculus,Phosphoinositide phospholipase C-eta-2,Phosphoinositide phospholipase C-like 4,Phospholipase C-eta-2,Phospholipase C-
EIAAB29647 Homo sapiens,Human,Phosphatidylcholine 2-acylhydrolase-like protein GIIC,PLA2G2C,Putative inactive group IIC secretory phospholipase A2
EIAAB31405 Homo sapiens,hPLB,Human,Phospholipase B,Phospholipase B_lipase,Phospholipase B1, membrane-associated,PLB,PLB_LIP,PLB1
EIAAB31404 Phlpb,Phospholipase B,Phospholipase B_lipase,Phospholipase B1, membrane-associated,PLB_LIP,Plb1,Rat,Rattus norvegicus
EIAAB31406 Mouse,Mus musculus,Phospholipase B,Phospholipase B_lipase,Phospholipase B1, membrane-associated,Plb,PLB_LIP,Plb1
EIAAB10715 Bos taurus,Bovine,DDHD domain-containing protein 1,DDHD1,PA-PLA1,Phosphatidic acid-preferring phospholipase A1,Phospholipase DDHD1
EIAAB29640 GIIC sPLA2,Group IIA phospholipase A2,Homo sapiens,Human,Non-pancreatic secretory phospholipase A2,NPS-PLA2,Phosphatidylcholine 2-acylhydrolase 2A,Phospholipase A2, membrane associated,PLA2B,PLA2G2A,P
EIAAB31564 Adipose triglyceride lipase,ATGL,Calcium-independent phospholipase A2,Desnutrin,FP17548,Homo sapiens,Human,IPLA2-zeta,Patatin-like phospholipase domain-containing protein 2,Pigment epithelium-derived

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Pathways :
WP1689: Porphyrin and chlorophyll metabolism
WP1624: Bacterial secretion system
WP1673: Naphthalene and anthracene degradation
WP1692: Protein export
WP1700: Selenoamino acid metabolism
WP1714: Tyrosine metabolism
WP1963: The effect of Glucocorticoids on target gene expression
WP1049: G Protein Signaling Pathways
WP1165: G Protein Signaling Pathways
WP1371: G Protein Signaling Pathways
WP1438: Influenza A virus infection
WP1493: Carbon assimilation C4 pathway
WP1502: Mitochondrial biogenesis
WP1531: Vitamin D synthesis
WP1566: Citrate cycle (TCA cycle)
WP1581: Histidine metabolism
WP1613: 1,4-Dichlorobenzene degradation
WP1616: ABC transporters
WP1625: Base excision repair
WP1644: DNA replication
WP1650: Fluorobenzoate degradation
WP1654: gamma-Hexachlorocyclohexane degradation
WP1657: Glycerolipid metabolism
WP1659: Glycine, serine and threonine metabolism
WP1661: Glyoxylate and dicarboxylate metabolism

Related Genes :
[ibpA p76 HSM_1489] Protein adenylyltransferase and cysteine protease IbpA (HMW IgBP) (p120) [Cleaved into: Protein p76 IgBP (76 kDa antigen)] [Includes: Protein adenylyltransferase IbpA (EC 2.7.7.n1) (AMPylator IbpA); Cysteine protease IbpA (EC 3.4.22.-)]
[PLBD1] Phospholipase B-like 1 (EC 3.1.1.-) (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1) [Cleaved into: Phospholipase B-like 1 chain A; Phospholipase B-like 1 chain B; Phospholipase B-like 1 chain C]
[PLBD1] Phospholipase B-like 1 (EC 3.1.1.-) (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1) [Cleaved into: Phospholipase B-like 1 chain A; Phospholipase B-like 1 chain B; Phospholipase B-like 1 chain C]
[Pla2g6 Pnpla9] 85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9)
[PLA2G6 PLPLA9] 85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9)
[Pla2g6 Pnpla9] 85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9)
[PLA2R1 CLEC13C] Secretory phospholipase A2 receptor (PLA2-R) (PLA2R) (180 kDa secretory phospholipase A2 receptor) (C-type lectin domain family 13 member C) (M-type receptor) [Cleaved into: Soluble secretory phospholipase A2 receptor (Soluble PLA2-R) (Soluble PLA2R)]
[PreS1 Large S P preS1 PreS1-S preS1-S preS2 S] Large envelope protein (L glycoprotein) (L-HBsAg) (LHB) (Large S protein) (Large surface protein) (Major surface antigen)
[] Genome polyprotein [Cleaved into: Capsid protein C (Capsid protein) (Core protein); Protein prM (Precursor membrane protein); Peptide pr (Peptide precursor); Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Peptide 2k; Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (Non-structural protein 5)]
[Pla2g16 H-rev107 Hrasls3 Hrev107] HRAS-like suppressor 3 (HRSL3) (EC 3.1.1.32) (EC 3.1.1.4) (Adipose-specific phospholipase A2) (AdPLA) (Group XVI phospholipase A2) (H-rev 107 protein homolog)
[] Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
[1a] Replicase polyprotein 1a (pp1a) (ORF1a polyprotein) [Cleaved into: Non-structural protein 1 (nsp1) (Leader protein); Non-structural protein 2 (nsp2) (p65 homolog); Non-structural protein 3 (nsp3) (EC 3.4.19.12) (EC 3.4.22.69) (PL2-PRO) (Papain-like proteinase) (PL-PRO) (SARS coronavirus main proteinase); Non-structural protein 4 (nsp4); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (nsp5); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7); Non-structural protein 8 (nsp8); Non-structural protein 9 (nsp9); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL); Non-structural protein 11 (nsp11)]
[] Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
[] Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
[PLA2G1B] Phospholipase A2 (EC 3.1.1.4) (Group IB phospholipase A2) (Phosphatidylcholine 2-acylhydrolase 1B) [Cleaved into: Phospholipase A2 isoform 2] (Fragment)
[] Genome polyprotein [Cleaved into: P1 proteinase (EC 3.4.-.-) (N-terminal protein); Helper component proteinase (HC-pro) (EC 3.4.22.45); Protein P3; 6 kDa protein 1 (6K1); Cytoplasmic inclusion protein (CI) (EC 3.6.4.-); 6 kDa protein 2 (6K2); Viral genome-linked protein (VPg); Nuclear inclusion protein A (NI-a) (NIa) (EC 3.4.22.44) (49 kDa proteinase) (49 kDa-Pro) (NIa-pro); Nuclear inclusion protein B (NI-b) (NIb) (EC 2.7.7.48) (RNA-directed RNA polymerase); Capsid protein (CP) (Coat protein)]
[Pla2r1 Pla2g1br] Secretory phospholipase A2 receptor (PLA2-R) (PLA2R) (180 kDa secretory phospholipase A2 receptor) (M-type receptor) [Cleaved into: Soluble secretory phospholipase A2 receptor (Soluble PLA2-R) (Soluble PLA2R)]
[Pla2g1b Pla2] Phospholipase A2 (EC 3.1.1.4) (Group IB phospholipase A2) (PLA2-Ib) (Phosphatidylcholine 2-acylhydrolase 1B)
[] Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[PLA2R1] Secretory phospholipase A2 receptor (PLA2-R) (PLA2R) (180 kDa secretory phospholipase A2 receptor) (M-type receptor) [Cleaved into: Soluble secretory phospholipase A2 receptor (Soluble PLA2-R) (Soluble PLA2R)]
[] Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
[PLA2G16 HRASLS3 HREV107] HRAS-like suppressor 3 (HRSL3) (EC 3.1.1.32) (EC 3.1.1.4) (Adipose-specific phospholipase A2) (AdPLA) (Group XVI phospholipase A1/A2) (H-rev 107 protein homolog) (H-REV107) (HREV107-1) (HRAS-like suppressor 1) (HREV107-3) (Renal carcinoma antigen NY-REN-65)
[PLA2G1B PLA2 PLA2A PPLA2] Phospholipase A2 (EC 3.1.1.4) (Group IB phospholipase A2) (Phosphatidylcholine 2-acylhydrolase 1B)
[PRDX6 AOP2 KIAA0106] Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Liver 2D page spot 40) (Non-selenium glutathione peroxidase) (NSGPx) (Red blood cells page spot 12)
[PLA2G4A CPLA2 PLA2G4] Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]
[plc-1 F31B12.1] 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-epsilon plc-1) (Phosphoinositide-specific phospholipase PLC210) (Phospholipase C-epsilon plc-1) (PLC-epsilon plc-1)
[PLA2G1B] Phospholipase A2, major isoenzyme (EC 3.1.1.4) (Group IB phospholipase A2) (Phosphatidylcholine 2-acylhydrolase 1B)
[PLA2G1B] Phospholipase A2 (EC 3.1.1.4) (Group IB phospholipase A2) (Phosphatidylcholine 2-acylhydrolase 1B)
[pldA b3821 JW3794] Phospholipase A1 (EC 3.1.1.32) (EC 3.1.1.4) (Detergent-resistant phospholipase A) (DR-phospholipase A) (Outer membrane phospholipase A) (OM PLA) (OMPLA) (Phosphatidylcholine 1-acylhydrolase)
[gag-pol] Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]

Bibliography :
?>